These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5935708)

  • 1. In vivo metabolism of H3-medroxyprogesterone acetate in pregnant and nonpregnant women and in the fetus.
    Besch PK; Vorys N; Ullery JC; Barry RD; Couri D
    Am J Obstet Gynecol; 1966 May; 95(2):228-38. PubMed ID: 5935708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentration of estrone, estradiol and estriol in the blood of pregnant sheep after induction of estrus with chlormadinone acetate and medroxyprogesterone acetate].
    Halagan J; Arendarcik J
    Vet Med (Praha); 1976 Sep; 21(9):551-6. PubMed ID: 66795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of breast cancer with medroxyprogesterone acetate.
    Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
    Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes.
    Ladisich W
    Psychoneuroendocrinology; 1977; 2(3):257-66. PubMed ID: 561984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of seizures with medroxyprogesterone acetate: preliminary report.
    Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC
    Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for medroxyprogesterone acetate (Provera) using the 11alpha-hydroxy succinyl conjugate.
    Royer ME; Ko H; Campbell JA; Murray HC; Evans JS; Kaiser DG
    Steroids; 1974 May; 23(5):713-30. PubMed ID: 4365969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsuccessful treatment of acromegaly with medroxyprogesterone acetate.
    Atkinson RL; Dimond RC; Howard WJ; Earll JM
    Acta Endocrinol (Copenh); 1974 Sep; 77(1):19-25. PubMed ID: 4408390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy.
    Turner SJ; Mizock GB; Feldman GL
    Am J Obstet Gynecol; 1966 May; 95(2):222-7. PubMed ID: 5935707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
    Laatikainen T; Nieminen U; Adlercreutz H
    Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat.
    Algeri S; Ponzio F; Dolfini E; Jori A
    Neuroendocrinology; 1976; 22(4):343-51. PubMed ID: 1030500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraceptive and endometrial effects of medroxyprogesterone acetate.
    Lee RA
    Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.